These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38738812)

  • 21. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
    Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
    Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
    Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Rashed ER; Ruiz Maya T; Black J; Fettig V; Kadian-Dodov D; Olin JW; Mehta L; Gelb BD; Kontorovich AR
    Vasc Med; 2022 Jun; 27(3):283-289. PubMed ID: 35000503
    [No Abstract]   [Full Text] [Related]  

  • 25. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Brock I; Prendergast W; Maitland A
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative measures of tissue mechanics to detect hypermobile Ehlers-Danlos syndrome and hypermobility syndrome disorders: a systematic review.
    Palmer S; Denner E; Riglar M; Scannell H; Webb S; Young G
    Clin Rheumatol; 2020 Mar; 39(3):715-725. PubMed ID: 31955324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone parameters in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: A comparative cross-sectional study.
    Coussens M; Banica T; Lapauw B; De Wandele I; Rombaut L; Malfait F; Calders P
    Bone; 2023 Jan; 166():116583. PubMed ID: 36243401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered Multisegment Ankle and Foot Kinematics During Gait in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder: A Case-Control Study.
    Vermeulen S; De Mits S; De Ridder R; Calders P; De Schepper J; Malfait F; Rombaut L
    Arthritis Care Res (Hoboken); 2022 May; 74(5):841-848. PubMed ID: 33275840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trajectory of hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older adults.
    Anderson LK; Lane KR
    J Am Assoc Nurse Pract; 2023 Oct; 35(10):605-612. PubMed ID: 37261967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An exploratory study of clinical characteristics and gait features of adolescents with hypermobility disorders.
    de Koning LE; Scheper MC; Ploeger HE; Warnink-Kavelaars J; Oosterlaan J; Bus SA; Engelbert RHH
    Gait Posture; 2023 Feb; 100():222-229. PubMed ID: 36638668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.
    Alsiri N; Alhadhoud M; Alkatefi T; Palmer S
    Semin Arthritis Rheum; 2023 Feb; 58():152127. PubMed ID: 36462303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
    Pezaro DS; Pearce DG; Reinhold DE
    Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Muscle Strength Change Over Time in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder? An Eight-Year Follow-Up Study.
    Coussens M; Calders P; Lapauw B; Celie B; Banica T; De Wandele I; Pacey V; Malfait F; Rombaut L
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):1041-1048. PubMed ID: 32293111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older women: A feasibility study.
    Anderson LK; Lane KR
    Musculoskeletal Care; 2023 Sep; 21(3):741-748. PubMed ID: 36864687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of MTHFR Polymorphisms in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobile Spectrum Disorders in a US Hypermobility Clinic.
    Courseault J; Umar M; Bordnick P; Simons J; Volic M; Stock A; Bix G
    ACR Open Rheumatol; 2024 Mar; ():. PubMed ID: 38523329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study.
    Knight DRT; Bruno KA; Singh A; Munipalli B; Gajarawala S; Solomon M; Kocsis SC; Darakjian AA; Jain A; Whelan ER; Kotha A; Gorelov DJ; Phillips SD; Fairweather D
    Front Cardiovasc Med; 2024; 11():1332508. PubMed ID: 38562189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Societal participation in ehlers-danlos syndromes and hypermobility spectrum disorder, compared to fibromyalgia and healthy controls.
    De Baets S; Cruyt E; Calders P; Dewandele I; Malfait F; Vanderstraeten G; Van Hove G; van De Velde D
    PLoS One; 2022; 17(6):e0269608. PubMed ID: 35709306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.